Hey mikyc, I thinks you asked to see my figures for the TXMD portfolio, so here they are, a word of caution though, the data is not as clean as for Nextstellis as the company has never disclosed units for each product, so NSP is not possible and in some cases the total figure was derived from deducting the $ for Nextstellis from WH.
After a slow start, I believe we are now seeing the revenues that TXMD extracted under their ownership for the last 3-9 months. Keep in mind that they threw the kitchen sink at it for that period. Anyway I hope it helps you.
$A/$US
0.68
0.68
0.68
0.68
0.67
0.67
0.63
1
Last 9mths
Last 3mths
2
Under TXMD(9)
Under TXMD(3)
2HFY23
1HFY24
2HFY24
1st4mthFY25
1HFY25 Fcast
3
Annovera
$37.20
$10.42
$12.16
$15.82
$21.98
4
Imvexxy
$20.58
$6.95
$6.34
$10.78
$8.42
5
Bijuva
$7.88
$2.66
$2.86
$5.04
$4.46
6
Other(Vits)
$2.67
$0.89
$2.22
$1.84
$2.87
7
Total $US
$68.33
$20.92
$23.58
$33.48
$37.74
$27.09
$40.63
8
/mth $US
$7.59
$6.97
$3.93
$5.58
$6.29
$6.77
$6.77
9
Run Rate $A
$133.97
$123.04
$83.22
$98.46
$112.64
$121.30
$129.00
MYX Price at posting:
$5.64 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)